中西医结合单元疗法治疗急性冠脉综合征的成本效果分析

Cost-Effectiveness Analysis of Acute Coronary Syndrome Treated by Unit Integrated Chinese and Western Medicine

目的中西医结合冠心病单元疗法治疗急性冠脉综合征(ACS)的成本效果分析。方法将入选的ACS病例随机分为中西医结合冠心病单元组(治疗组)和中西医结合非冠心病单元组(对照组)。两组患者在遵循相关指南予以西医常规诊疗的同时,治疗组依照辨证施治方案规范中医诊疗,并进行中医特色情志干预及健康教育康复指导等辅助治疗;对照组采用传统的中医诊疗,不进行辅助治疗。对两种治疗方案进行成本效果分析。结果共147例纳入研究,脱落18例,129例纳入分析,分为治疗组72例、对照组57例。治疗组与对照组心绞痛疗效的总有效率分别为91.67%和82.46%(P<0.05);治疗组、对照组成本效果比分别为123.91元和147.94元,治疗组低于对照组;治疗组、对照组调整后成本效果比分别为114.83元和137.05元,治疗组仍低于对照组。结论中西医结合冠心病单元疗法治疗ACS较非单元治疗更加经济、有效。

Objective To make a cost-effectiveness analysis of acute coronary syndrome （ACS） patients treated by CAD unit integrated TCM and western medicine. Methods 147 ACS patients were assigned into CAD unit integrated TCM and western medicine（ treatment group） and CAD non-unit integrated TCM and western medicine （control group）. Two groups were both diagnosed and treated with western medicine guideline. Meanwhile, the treatment group patients were diagnosed and treated normally according to TCM standard. Besides, we had made aid treatment to the treatment group patients, including mental intervention and heahhcare instruction. The control group patients were not diagnosed and treated with TCM standard and didn ＇ t receive aid treatment. The cost-effectiveness analysis of two groups were made. Results The effective rate of angina in the treatment group was 91.67%, which was higher than 82.46% in the control group（ P 〈0.05 ）. Cost-effectiveness rates of two groups were ￥ 123.91 and ￥ 147.94, the treatment group was lower than the control group; cost-effectiveness rates after adjustment of two groups were ￥ 114.83 and ￥ 137.05, the treatment group was still lower than the control group. Conculsion The CAD unit integrated TCM and western medicine is more economical and effective than CAD non-unit integrated TCM and western medicine in the treatment of ACS.